Blog Source: www.rxtimes.com
14 — Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced publication of a Phase 1 clinical study(1) on ...
Blog Source: www.healthexperiment.com
Society. According to National Cancer Institute figures, there will be about 66120 new cases of NHL in the United States in 2008, and 19160 deaths. NHL can involve either B or T immune cells. Blinatumomab targets that ...
Blog Source: blogs.discovermagazine.com
In patients with non-Hodgkin’s lymphoma, researchers have found a way to turn cells in the patients’ own immune system into cancer-fighting machines. In a new study, researchers injected patients with a drug that helped immune cells ...
Blog Source: www.neatorama.com
In another study hailed as a breakthrough, doctors announced that some patients with non-Hodgkin’s lymphoma saw their cancer disappear after being treated with a new drug that boost their own immune cells: ...
Blog Source: john-ray.blogspot.com
Cancer patients have been left free of the disease after being treated with a new drug which harnesses the power of their own immune cells. Four of 38 patients with non-Hodgkin's lymphoma have seen the disease disappear following ...
Blog Source: nshack-sports.blogspot.com
By Roselyn Capen The stage of breast cancer when cancer cells do not remain in the original... cancer, there is a chance that some cancer cells do not die, and later spread out through blood